In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens-Reference-Cited by-同舟云学术

In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens

Published:2021-05 Issue:5 Volume:57 Page:106323
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Nguyen Hang Thi,Venter Henrietta,Veltman Tania^ORCID,Williams Ruth^ORCID,O'Donovan Lisa Anne^ORCID,Russell Cecilia C.,McCluskey Adam,Page Stephen W.,Ogunniyi Abiodun David^ORCID,Trott Darren J.

Funder

Australian Research Council

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference40 articles.

1. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement;Chopra;Lancet Infect Dis,2008

2. Clinical relevance of the ESKAPE pathogens;Pendleton;Expert Rev Anti Infect Ther,2013

3. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program;Diekema;Antimicrob Agents Chemother,2019

4. Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980–2009;Outterson;J Law Med Ethics,2013

5. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria;Arzanlou;Essays Biochem,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bavachin Rejuvenates Sensitivity of Colistin against Colistin-Resistant Gram-Negative Bacteria;International Journal of Molecular Sciences;2024-02-16

2. Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics;ACS Medicinal Chemistry Letters;2024-01-09

3. Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in Escherichia coli;ACS Infectious Diseases;2023-10-27

4. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model;Antimicrobial Agents and Chemotherapy;2023-10-18

5. Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics;Frontiers in Microbiology;2023-09-05